MIUDELLA
SEBELA WOMENS HLTH · COPPER
Open FDA's page for this record- Application number
- NDA218201
- Sponsor name
- SEBELA WOMENS HLTH
- Submissions
- Submission type
- ORIG
- Submission number
- 1
- Submission status
- AP
- Submission status date
- 20250224
- Review priority
- STANDARD
- Submission class code
- TYPE 5
- Submission class code description
- Type 5 - New Formulation or New Manufacturer
- Application docs
- ID
- 81343
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/218201Correcteds000lbl.pdf
- Date
- 20250225
- Type
- Label
- ID
- 81368
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/218201Orig1s000ltr.pdf
- Date
- 20250225
- Type
- Letter
- Submission type
- SUPPL
- Submission number
- 2
- Submission status
- AP
- Submission status date
- 20251001
- Review priority
- N/A
- Submission class code
- REMS
- Submission class code description
- REMS
- Application docs
- ID
- 83635
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/218201Orig1s002ltr.pdf
- Date
- 20251003
- Type
- Letter
- ID
- 83636
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/218201Orig1s002ltr.pdf
- Date
- 20251003
- Type
- Letter
- ID
- 83637
- Url
- https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/218201Orig1s002ltr.pdf
- Date
- 20251003
- Type
- Letter
- Products
- Product number
- 001
- Reference drug
- Yes
- Brand name
- MIUDELLA
- Reference standard
- Yes
- Dosage form
- SYSTEM
- Route
- INTRAUTERINE
- Marketing status
- Prescription
- Active ingredients
- Name
- COPPER
- Strength
- N/A
